Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells
June 16th, 2019
Here, we present several simple methods for evaluating viability and death in 3D cancer cell spheroids, which mimic the physico-chemical gradients of in vivo tumors much better than the 2D culture. The spheroid model, therefore, allows evaluation of the cancer drug efficacy with improved translation to in vivo conditions.
Overview
This article presents optimized protocols for evaluating cancer cell viability and death in 3D spheroid cultures, which better mimic in vivo tumor conditions compared to traditional 2D cultures. These methods enhance the assessment of cancer drug efficacy and facilitate improved translation to in vivo environments.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Cancer Research
Background
- 3D cultures replicate key aspects of the tumor microenvironment.
- They provide a more accurate model for studying cancer cell behavior.
- 3D spheroids are increasingly used in cancer drug screening.
- Protocols may require practice and skill for effective execution.
Purpose of Study
- To develop methods for evaluating cancer cell growth and death in a 3D environment.
- To improve the translation of in vitro findings to in vivo conditions.
- To provide accessible protocols for researchers in cancer therapy.
Methods Used
- Hand drop method for spheroid production.
- Embedding spheroids for immunohistochemistry.
- Visual demonstrations to assist in protocol execution.
- Evaluation of drug efficacy using 3D spheroid models.
Main Results
- Protocols allow for efficient investigation of cancer cell processes.
- 3D cultures enhance understanding of drug responses.
- Visual aids improve the reproducibility of complex procedures.
- Findings support the use of 3D models in cancer research.
Conclusions
- 3D spheroid cultures are valuable for cancer research.
- Optimized protocols facilitate better experimental outcomes.
- Improved translation of results to clinical settings is achievable.
Frequently Asked Questions
Executive Industry Relevance
Three-dimensional spheroid cultures provide a physiologically relevant platform for evaluating cancer cell viability and death, directly addressing the translational gap between in vitro and in vivo drug response. These models enable more predictive assessment of anticancer compound efficacy by recapitulating tumor microenvironmental gradients and cell-cell interactions. Their adoption supports higher-confidence decision-making at the early discovery and preclinical inflection points in oncology pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of therapeutic hypotheses in a tumor-mimetic context.
- Supports functional target validation by modeling in vivo-like gradients and interactions.
- Facilitates mechanistic de-risking through spatially resolved viability and death readouts.
- Improves predictive confidence for portfolio triage in oncology programs.
Screening & Assay Development
- Prepares validated 3D biological systems for high-throughput drug screening workflows.
- Standardizes viability and death assays for reproducible, quantitative outputs.
- Enables scalable compound evaluation with physiologically relevant endpoints.
- Supports platform reuse across diverse cancer cell types and drug classes.
Translational & Preclinical Research
- Aligns in vitro findings with in vivo tumor biology for improved translational continuity.
- Facilitates risk-adjusted advancement decisions based on more predictive efficacy data.
- Enables co-culture with stromal or immune cells to model tumor microenvironment complexity.
- Supports biomarker discovery and validation in disease-relevant systems.
Pipeline & Workflow Integration
3D spheroid viability and death assessment bridges early discovery, lead identification, and preclinical validation in oncology R&D workflows.
- Discovery Biology: Provides a platform for hypothesis testing and mechanistic de-risking in tumor-like conditions.
- Screening: Delivers reproducible, quantitative viability and death measurements for compound triage.
- Analytics: Enables spatial and dose-dependent analysis of cell death using imaging and fluorescence readouts.
- Translational Research: Supports continuity from in vitro screening to in vivo efficacy studies.
- Enterprise Reuse: Offers a versatile, scalable system adaptable to multiple cancer models and assay formats.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in oncology discovery.
- Operational Value: Standardizes and scales viability and death assays for robust, reproducible outputs.
- Strategic Value: Enables better go/no-go decisions and capital efficiency by improving translational relevance.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of oncology assets.
Implementation Considerations
- Requires technical expertise in 3D culture handling and imaging analysis.
- Needs access to specialized plates, imaging systems, and analytical software.
- Demands cross-team standardization for reproducibility across sites and studies.
- Adaptation may be necessary for different cancer cell types and co-culture systems.
- Some protocols, such as hand drop spheroid formation, require practice for consistency.
Biopharma FAQs
Chapters in this video
0:04
Title
0:59
Spontaneous Spheroid Formation
1:45
Reconstituted Basement Membrane-mediated Spheroid Formation
3:04
Hanging Drop Spheroids
4:14
Preparing Protein Lysates for Western Blotting from 3D Spheroid Cultures
5:21
Propidium Iodide (PI) Staining of Spheroids
6:27
Embedding of Spheroids
7:52
Results: Assessing Cell Viability and Death
9:24
Conclusion
